Merck’s stock drops as mixed outlook offsets earnings beat on Keytruda strength

Date:

July 30, 2024

Merck’s stock was headed lower in early trading Tuesday, after the drugmaker reported second-quarter profit and sales that beat expectations, amid strength in sales of cancer treatment Keytruda, but provided a mixed full-year outlook.

Source link

Taylor Swift Reacts After Stabbing at Swift-Themed Event That Left 2 Dead

What is that? Olympic Phryge confounds some, but is very French

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Merck’s stock drops as mixed outlook offsets earnings beat on Keytruda strength

Recent posts

The floodgates on the IPO market are unlikely to open before yearend

Biden offers latest debate excuse as Harris pulls level in one betting market

Investors question Fed’s rate cut amid signs of faster economic growth

Harris now leads Trump in swing-state polls, according to one polling average

Trump’s plans for deportations, tariffs and the Fed will jack up inflation, economists say

B. Riley Financial’s stock drops 30% after it suspends dividend and projects a loss

Colgate-Palmolive beats profit views, even as prices fall in North America again

Perrigo voluntarily recalls 16,500 cans of baby formula because of excessive levels of vitamin D

Natural-gas prices have dropped during the hottest summer ever, thanks to Europe

Investing legend Howard Marks shares how investors can take advantage of ‘irrational’ markets

Bond investors position for new debt from Goldman Sachs and Morgan Stanley

Oil on track for back-to-back gain on China stimulus, lingering Middle East worries

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Boeing’s confidence in Starliner ‘speaks volumes,’ says former NASA astronaut

This chart shows gold vs. the stock market since Bernanke’s famous helicopter drop speech

Related articles

Honeywell announces a new collaboration with Bombardier. But it’ll weigh on this year’s profit.

Trump’s tax plans: Housing credits ‘in play,’ and there’s buzz over a short extension for expiring cuts

Why Super Micro’s stock is soaring after completion of accounting probe

More retailers report this week, amid signs of solid online holiday spending

A rising U.S. dollar could cause trouble for stock-market bulls

Hemp-based THC revenue may make cannabis stocks more appealing—but there are risks

Kohl’s has a new CEO, but not enough of the things its shoppers depend on

Nordstrom nudges its sales outlook higher. And its off-price stores continue to help results.

Company

Follow us